Literature DB >> 34882253

Metronidazole and ciprofloxacin differentially affect chronic unpredictable mild stress-induced changes in the colon, cecum and ileum microbiota.

Chen Meng1,2, Chen Dong3, Hong Liu4,5,6.   

Abstract

Antibiotics have been shown to have a major impact on the composition and metabolism of gut microbiota, while unpredictable stress has been shown to have major influences on gut microbiota homeostasis. However, the impact of combination antibiotics (e.g. metronidazole and ciprofloxacin) on gut microbiota dysbiosis that is induced by stress remains unclear. Here, chronic unpredictable mild stress (CUMS) was used to simulate unpredictable stress, and Sprague-Dawley rats received antibiotics (metronidazole and ciprofloxacin) after CUMS. The weights and coefficients of the thymus, liver and spleen were analysed. 16S rRNA gene sequencing was performed to determine the gut microbiota in the colon, cecum and ileum. We found that antibiotics decreased the CUMS-induced increases in spleen coefficients. Short-term antibiotic exposure significantly increased the cecum and ileum microbiota richness and significantly increased the ileum microbiota diversity after CUMS. Long-term antibiotic exposure significantly decreased the colon microbiota diversity and significantly increased the ileum microbiota richness after CUMS. The impacts of antibiotic exposure on the microbiota compositions at the phylum and genus levels in different gut segments were different after CUMS. However, it is worth noting that the most differentially abundant bacteria in the colon, cecum and ileum were all Verrucomicrobia under long-term antibiotic exposure. Antibiotic exposure significantly increased the relative abundance of Lactobacillus in the colon and ileum and significantly increased the relative abundance of Akkermansia in the colon and cecum after CUMS. In conclusion, this study showed that metronidazole and ciprofloxacin differentially affected the CUMS-induced changes in the microbiota of the colon, cecum and ileum.Key points• The impacts of antibiotic exposure on the changes in microbiota that were induced by chronic unpredictable mild stress were analysed.• We collected rat gut microorganisms from the colon, cecum and ileum.• The diversities, compositions, functions and network structures were analysed.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  16S rRNA; Chronic unpredictable mild stress; Ciprofloxacin; Gut microbiota; Gut segment; Metronidazole

Mesh:

Substances:

Year:  2021        PMID: 34882253     DOI: 10.1007/s00253-021-11685-1

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  28 in total

1.  Turicibacter sanguinis gen. nov., sp. nov., a novel anaerobic, Gram-positive bacterium.

Authors:  Philipp P Bosshard; Reinhard Zbinden; Martin Altwegg
Journal:  Int J Syst Evol Microbiol       Date:  2002-07       Impact factor: 2.747

2.  Gut microbiota - at the intersection of everything?

Authors:  Patrice D Cani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-04-26       Impact factor: 46.802

Review 3.  Minireview: Gut microbiota: the neglected endocrine organ.

Authors:  Gerard Clarke; Roman M Stilling; Paul J Kennedy; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Mol Endocrinol       Date:  2014-06-03

4.  High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment.

Authors:  Grégory Dubourg; Jean-Christophe Lagier; Fabrice Armougom; Catherine Robert; Gilles Audoly; Laurent Papazian; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2013-01-05       Impact factor: 5.283

Review 5.  Akkermansia muciniphila and its role in regulating host functions.

Authors:  Muriel Derrien; Clara Belzer; Willem M de Vos
Journal:  Microb Pathog       Date:  2016-02-11       Impact factor: 3.738

6.  The natural history of antibiotics.

Authors:  Jon Clardy; Michael A Fischbach; Cameron R Currie
Journal:  Curr Biol       Date:  2009-06-09       Impact factor: 10.834

Review 7.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

Review 8.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 9.  The Microbiota-Gut-Brain Axis.

Authors:  John F Cryan; Kenneth J O'Riordan; Caitlin S M Cowan; Kiran V Sandhu; Thomaz F S Bastiaanssen; Marcus Boehme; Martin G Codagnone; Sofia Cussotto; Christine Fulling; Anna V Golubeva; Katherine E Guzzetta; Minal Jaggar; Caitriona M Long-Smith; Joshua M Lyte; Jason A Martin; Alicia Molinero-Perez; Gerard Moloney; Emanuela Morelli; Enrique Morillas; Rory O'Connor; Joana S Cruz-Pereira; Veronica L Peterson; Kieran Rea; Nathaniel L Ritz; Eoin Sherwin; Simon Spichak; Emily M Teichman; Marcel van de Wouw; Ana Paula Ventura-Silva; Shauna E Wallace-Fitzsimons; Niall Hyland; Gerard Clarke; Timothy G Dinan
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

10.  Dysbiosis of the gut microbiota in disease.

Authors:  Simon Carding; Kristin Verbeke; Daniel T Vipond; Bernard M Corfe; Lauren J Owen
Journal:  Microb Ecol Health Dis       Date:  2015-02-02
View more
  1 in total

1.  Development of Early-Life Gastrointestinal Microbiota in the Presence of Antibiotics Alters the Severity of Acute DSS-Induced Colitis in Mice.

Authors:  Xiaojun Li; Yu Ren; Jie Zhang; Chunhui Ouyang; Chunlian Wang; Fanggen Lu; Yani Yin
Journal:  Microbiol Spectr       Date:  2022-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.